Page last updated: 2024-10-28

p-hydroxyamphetamine and Diabetic Neuropathies

p-hydroxyamphetamine has been researched along with Diabetic Neuropathies in 1 studies

p-Hydroxyamphetamine: Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, SA1
Smith, SE1

Other Studies

1 other study available for p-hydroxyamphetamine and Diabetic Neuropathies

ArticleYear
Evidence for a neuropathic aetiology in the small pupil of diabetes mellitus.
    The British journal of ophthalmology, 1983, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Aging; Darkness; Diabetic Neuropathies; Humans; Iris; Middle Aged; p-Hydroxyamphe

1983